KIR2DL1 and Miyoshi myopathy: As summarized in Table 2, when the expression of biomarkers on NK cells from HD was compared to each of the MM subtypes, most of the differences were concentrated in RR and pSCT patients, where the NK cells tend to be less mature (increased immature CD56bright cells and lower expression of FcγRIIIa (CD16) and KIR2DL1/S1 on CD56dim NK cells; Figure 1).